According to a recent online article, Simmerman Law Office, PLLC recently filed a lawsuit in the Northern District of West Virginia against Mylan Pharmaceuticals, as local counsel, alleging that Mylan committed patent violations.  Per the article, the plaintiffs are seeking a judgment that Mylan has infringed on the three patents; a judgment that the effective day of any approval of Mylan’s ANDA is not earlier than the day after the expiration of the three patents; a judgment declaring and permanently enjoining the defendants from making, using, offering to sell, selling or importing of the Mylan generic tablets and that it would constitute infringement; and compensatory damages.